Emergent BioSolutions Inc. Business Finance Contracts & Agreements
120 Contracts & Agreements
- Credit Agreements (9 contracts)
- Exchange Agreements (5)
- Indenture Agreements (3)
- Loan Agreements (10)
- Modification Agreements (59)
- Note Agreements (4)
- Purchase Agreements (3)
- Registration Rights Agreements (4)
- Stock Agreements (21)
- Subscription Agreements (1)
- Warrant Agreements (1)
- Form of Subscription Agreement, dated August 30, 2024, between Emergent BioSolutions Inc. and the Subscribing Entities (Filed With SEC on September 3, 2024)
- Form of Warrant (included in Exhibit 10.2) (Filed With SEC on September 3, 2024)
- Credit Agreement, dated as of August 30, 2024, by and among Emergent BioSolutions Inc., the lenders from time to time party thereto and OHA Agency LLC, as administrative agent (Filed With SEC on September 3, 2024)
- First Supplemental Indenture, dated as of August 30, 2024, by and among Emergent BioSolutions Inc., the subsidiary guarantors party thereto and U.S. Bank Trust Company, National... (Filed With SEC on September 3, 2024)
- Modification No. 29, effective June 16, 2022, to the CDC BioThrax Procurement Contract (Filed With SEC on August 2, 2022)
- Modification No. 28, effective April 14, 2022, to the CDC BioThrax Procurement Contract (Filed With SEC on August 2, 2022)
- Modification No. 27, effective March 31, 2022, to the Solicitation/Contract/Order for Commercial Items (the CDC BioThrax Procurement Contract), effective December 8, 2016, from... (Filed With SEC on April 29, 2022)
- Modification No. 32, effective November 1, 2021, to the BARDA ADM Contract (Filed With SEC on February 25, 2022)
- Modification No. 31, effective October 20, 2021, to the BARDA ADM Contract (Filed With SEC on February 25, 2022)
- Modification No. 8, effective (Filed With SEC on February 25, 2022)
- Modification No. 4, effective (Filed With SEC on February 25, 2022)
- Modification No. 3, effective (Filed With SEC on February 25, 2022)
- Modification No. 6, effective, November 1, 2021 to the ACAM2000 Contract (Filed With SEC on February 25, 2022)
- Modification No. 5, effective, September 29, 2021 to the ACAM2000 Contract (Filed With SEC on February 25, 2022)
- Modification No. 4, effective, July 13, 2021 to the ACAM2000 Contract (Filed With SEC on February 25, 2022)
- Modification No. 1 (Filed With SEC on February 25, 2022)
- Modification No. 26, effective November 1, 2021, to the CDC BioThrax Procurement Contract (Filed With SEC on February 25, 2022)
- Agreement to Terminate Class A Stockholders Registration Rights Agreement, dated December 9, 2021 by and among Emergent BioSolutions Inc., Intervac, L.L.C. and BioVac, L.L.C (Filed With SEC on February 25, 2022)
- Modification No. 25, effective September 29, 2021, to the CDC BioThrax Procurement Contract (Filed With SEC on November 5, 2021)
- Modification No. 24, effective February 2, 2021, to the Solicitation/Contract/Order for Commercial Items, effective December 8, 2016, from the Centers for Disease Control and... (Filed With SEC on November 5, 2021)
- Modification No. 11, effective September 30, 2021, to the BARDA AV7909 Contract (Filed With SEC on November 5, 2021)
- Modification No. 2, effective August 29, 2018, to the BARDA AV7909 Contract (Filed With SEC on November 5, 2021)
- Modification No. 1, effective March 16 2017, to the BARDA AV7909 Contract (Filed With SEC on November 5, 2021)
- Modification No. 1, effective (Filed With SEC on July 30, 2021)
- Modification No. 28, effective May 27, 2021, to the BARDA ADM Contract (Filed With SEC on July 30, 2021)
- Modification No. 10, effective June 10, 2021 to the BARDA AV7909 Contract (Filed With SEC on July 30, 2021)
- Modification No. 9, effective April 21, 2021, to the BARDA AV7909 Contract (Filed With SEC on July 30, 2021)
- Modification No. 8, effective March 22, 2021, to the BARDA AV7909 Contract (Filed With SEC on July 30, 2021)
- Modification No. 6, effective March 24, 2021, to Task Order 75A50120F33007 (Filed With SEC on April 30, 2021)
- Modification No. 5, effective February 22, 2021, to Task Order 75A50120F33007 (Filed With SEC on April 30, 2021)
- Modification No. 26, effective November 2, 2020 to the BARDA ADM Contract (Filed With SEC on February 19, 2021)
- Modification No. 2, effective November 17, 2020, to Task Order 75A50120F33008 (Filed With SEC on February 19, 2021)
- Modification No. 3, effective October 7, 2020, to Task Order 75A50120F33007 (Filed With SEC on February 19, 2021)
- Modification No. 2, effective September 18, 2020, to Task Order 75A50120F33007 (Filed With SEC on February 19, 2021)
- Modification No. 2, effective, October 28, 2020 to the ACAM 2000 Contract (Filed With SEC on February 19, 2021)
- Modification No. 23, effective September 30, 2020, to the CDC BioThrax Procurement Contract (Filed With SEC on February 19, 2021)
- Modification No. 2 (Filed With SEC on February 19, 2021)
- Modification No. 2 (Filed With SEC on February 19, 2021)
- Global Form of Restricted Stock Unit Award Agreement (Filed With SEC on February 19, 2021)
- Modification No. 1, effective August 24, 2020, to (Filed With SEC on November 6, 2020)
